1)TRAIL receptorTRAIL受体
1.The expression of TRAIL receptors in human prostate cancer;TRAIL受体在前列腺癌中的表达
2.TRAIL can initiate singnaling through binding to TRAIL receptors.但肿瘤细胞也可通过表达TRAIL,产生免疫逃逸或免疫赦免,且TRAIL的作用还受到NFκB或靶细胞表达TRAIL受体类型和数量的影响。
3.With deep research, the structure and function of TRAIL receptors are found to be more complicated than that of anticipated.TRAIL(TNF related apoptosis inducing ligand)是新发现的肿瘤坏死因子家族(TNF)成员,能够诱导多种肿瘤细胞凋亡,其中受体决定着TRAIL的生物学功能,在TRAIL诱导的细胞凋亡中发挥着重要作用,随着研究的不断深入,发现其受体的结构组成与功能比原先所认识的更为复杂,并且在组成结构与功能上存在不一致性,提示TRAIL受体对TRAIL功能的调节具有系统性,尚有许多待认识和研究的地方,本文仅对TRAIL受体的研究新进展进行综述。
英文短句/例句
1.Progress on targeting TRAIL’s receptor as antitumor strategy靶向TRAIL受体的抗肿瘤研究进展
2.The Study of the Sensitivity of Cervical Carcinoma Cell Towards Trail and the Expression Pattern of Trail Receptors;宫颈癌细胞对TRAIL诱导凋亡的敏感性及其表面TRAIL受体表达的研究
3.Experimental Study about Expressions of the Receptors of TRAIL in Human Carcinoma of Endometrium and Therapy on Carcinoma of Endometrium;TRAIL受体在子宫内膜癌中的表达和TRAIL治疗子宫内膜癌的试验性研究
4.Differential Expression of Death and Decoy Receptors for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Hepatocellular Carcinoma and Apoptosis Induced by TRAIL;TRAIL受体在人肝细胞癌中的表达及TRAIL诱导肝癌细胞调亡研究
5.Expressions and Roles of TRAIL Receptor DR5 and Ki67 on Primary Acute Leukemic Blasts;TRAIL受体DR5与Ki67在原代白血病细胞的表达和意义
6.Expression and clinical significance of DR5 and DcR1 for TNF-related apoptosis-inducing ligand (TRAIL) in endometrial carcinomaTRAIL受体DR5、DcR1在子宫内膜癌中的表达及临床意义
7.The Cytotoxicity Study of Monoclonal Antibodies Specific for TRAIL Receptors on Human Renal Cell Carcinoma, in Vitro and in Vivo;TRAIL受体单克隆抗体诱导人肾癌细胞凋亡的实验研究
8.Expression of TRAIL Receptors and Its Significance in Children with Acute LeukemiaTRAIL受体在儿童急性白血病中的表达及其临床意义
9.Expressions of FasL,TRAIL and its death receptor in tissue of cervical carcinomaFasL、TRAIL及其受体DcR1在宫颈癌中的表达
10.Expressions of TRAIL and its death receptor in tissue of cervical carcinomaTRAIL及其受体DR5、DcR1在宫颈癌中的表达
11.Expressions of TRAIL and Its Receptors in Rectal Cancer TissueTRAIL及其受体在直肠癌组织中的表达
12.The Expression of TRAIL and Its Receptors in Osteosarcoma Cells and the Apoptosis Effect of a Combination of TRAIL, Adriamycin and IFN-γ on MG-63 Cells in VitroTRAIL联合阿霉素和IFNγ对人骨肉瘤细胞及TRAIL相关受体影响的实验研究
13.The Apoptosis Role of TRAIL and Its Receptors in the Cervical Cancer Cell;TRAIL及其受体在宫颈癌细胞凋亡中的作用
14.The Role of the TRAIL and Its Receptors in Apoptosis of Ovarian Cancinoma Cells;TRAIL及其受体在卵巢癌细胞凋亡中的作用
15.Expression and Significance of TRAIL and Its Receptors DcR1, DR4 in Cervical Cancer Tissues;TRAIL及受体DcR1，DR4在宫颈癌组织中的表达及意义
16.Role of Caspase8 in the Induced Apoptosis of Neuroblastoma Cells Through TRAIL-death Receptor Pathway;Caspase8在TRAIL-死亡受体途径中诱导神经母细胞瘤细胞凋亡的作用
17.TRAIL and Its Receptors Play the Role in Villus of Early Spontaneous Abortion (SA);早孕绒毛TRAIL及其受体在自然流产中作用机制的研究
18.A Preliminary Study on the Relationship between the Levels of Plasma TRAIL, DR5 and OPG and Acute Coronary Syndrome;TRAIL及其受体DR5和OPG与急性冠脉综合征关系的初步研究
相关短句/例句
TRAIL receptorsTRAIL受体
1.Initial application of microarray biosensor detection system of TRAIL receptors;TRAIL受体微阵列生物传感器检测系统的初步应用
3)TRATL resistanceTRAIL耐受
4)Human TRAIL人TRAIL
1.Cloning of Human TRAIL cDNA and Its Expression in COS-7 Cells;人TRAIL基因cDNA的克隆及其在COS-7细胞中的表达
5)TNF-related apoptosis-inducing ligand肿瘤坏死因子相关的凋亡诱导配体(TRAIL)
6)TRAIL(TNF related apoptosis inducing ligand)TRAIL(肿瘤坏死因子相关的凋亡诱导配体)
延伸阅读
5-羟色胺受体阻断剂分子式：CAS号：性质：5-羟色胺（5-HT）是重要的神经递质，也是一种自身活性物质。5-HT通过与靶细胞膜上的5-HT受体结合并诱发生物效应。5-HT受体可分为5-HT1A，5-HT1B，5-HT1C，5-HT2，5-HT3。5-HT受体阻断药大致有以下几类，（1）麦角酸的衍生物如麦解酰二乙胺等；（2）组胺H1受体阻断药如赛庚啶等；（3）吩噻嗪类如氯丙嗪等；（4）肾上腺素α-受体阻断药如酚苄明等。常用于实验室研究、较为特异的5-HT受体阻断剂有麦角苄脂、米安色林、苯噻啶等。
